Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-01-13 @ 3:42 AM
Study NCT ID:
NCT01253551
Status:
COMPLETED
Last Update Posted:
2012-10-16
First Post:
2010-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Sponsor:
Tibotec BVBA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-02
First Submit QC Date:
None
Study First Post Date:
2010-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-13
Last Update Post Date:
2012-10-16
Last Update Post Date Type:
ESTIMATED